Laser Instrument Therapy for Varicose Veins: Mechanism, Standard Protocol and Clinical Application

Varicose veins arise from venous valve insufficiency, causing retrograde blood flow, vessel dilation and lower-extremity discomfort. Endovenous Laser Ablation (EVLA), also named Endovenous Laser Therapy (EVLT), has become the first-line minimally invasive intervention to replace conventional vein stripping surgery. This paper systematically elaborates how medical laser devices repair diseased superficial veins, including thermal mechanism, full clinical operating workflow, wavelength selection criteria, clinical merits, controllable risks and postoperative standardized management, providing professional reference for vascular practitioners.

1. Fundamental Thermal Mechanism of Laser Treatment
   Medical laser instruments cure varicose veins via precise photothermal effects. Ultra-thin sterile optical fibers deliver concentrated monochromatic laser energy directly inside the incompetent vein lumen under real-time duplex ultrasound guidance. Popular clinical wavelengths include 980 nm and 1470 nm; the 1470 nm laser demonstrates superior water absorption capacity, concentrating thermal damage on venous endothelium while sparing surrounding subcutaneous fat, nerves and muscle tissues.
   When laser activates, blood and intramural water molecules absorb photons and vaporize instantly, generating micro steam bubbles that transfer high temperature (over 80°C) to the venous wall. The sustained thermal stimulus triggers irreversible denaturation of collagen fibers in the tunica media, leading to immediate vessel contraction, endothelial necrosis and local thrombogenesis. In the following months, the human immune system gradually absorbs the scarred, sealed vein tissue, and systemic blood circulation automatically diverts to intact deep venous branches to eliminate blood stasis and swelling symptoms. Unlike sclerotherapy that only targets tiny reticular veins, laser devices effectively handle large-caliber great saphenous veins with diameters exceeding 6 mm.
2. Standard Operating Procedure of Laser Therapy
   The whole EVLA process is completed in an outpatient ward without general anesthesia, with the full procedure lasting 30 to 60 minutes per lower limb.
   First, preoperative duplex ultrasound precisely maps the course of defective veins and marks puncture sites on the skin surface. Physicians inject tumescent local anesthesia around the target vein; the fluid mixture of lidocaine and saline insulates heat, relieves pain and compresses the vein lumen to reduce blood flow interference.
   Second, a 2–3 mm percutaneous puncture introduces a flexible catheter sheath into the vein cavity. A thin laser fiber is threaded through the sheath and advanced to 2 cm below the saphenofemoral junction to avoid thermal injury to deep venous valves.
   Third, the laser host machine outputs calibrated energy at a fixed power density. Operators pull back the optical fiber at a constant speed of 1 cm per second. The laser console records total joules delivered per centimeter of vein to guarantee uniform closure. After fiber withdrawal, minor tributary varicosities are treated with supplementary transdermal low-power laser or foam sclerotherapy for complete aesthetic improvement.
   Finally, compression bandages are wrapped tightly around the leg, and patients are instructed to walk for 15 minutes immediately to prevent deep vein thrombosis (DVT).
3. Clinical Advantages and Potential Complications of Laser Devices
   EVLA outperforms traditional stripping surgery significantly. Laser treatment creates micro punctures without surgical incisions, leaving almost invisible scars. Postoperative recovery is rapid: most patients resume office work within 24 hours, while open surgery requires one week of rest. Long-term clinical follow-up proves the five-year vein occlusion rate of EVLA reaches 93% to 98%, with low recurrence rates compared with injection sclerotherapy.
   Complications associated with laser instruments are mild and rare with standardized operation. Temporary subcutaneous bruising, mild tenderness and transient superficial phlebitis occur in roughly 15% of patients and resolve spontaneously within two to four weeks. Severe adverse events such as endothermal heat-induced thrombosis (EHIT), skin burns and permanent saphenous nerve hypoesthesia happen in less than 1% of cases, mostly resulting from improper fiber positioning or excessive laser power output . High-precision modern laser equipment equipped with real-time temperature feedback sensors greatly cuts down thermal injury risks.
4. Postoperative Standardized Recovery Protocol
   After laser ablation, patients must wear grade 2 medical compression stockings for 4–6 weeks to stabilize venous remodeling. Moderate aerobic exercise like brisk walking boosts circulation, whereas heavy weightlifting and prolonged standing are prohibited for one month. Regular ultrasound reexaminations at 1 week, 3 months and 12 months monitor vein closure status and rule out secondary reflux.
5. Medical laser instruments achieve radical repair of varicose veins through controllable intraluminal thermal coagulation. Optimized wavelength matching, ultrasound navigation and standardized energy delivery maximize curative effects and minimize trauma. As laser hardware continues to upgrade with miniaturized fibers and intelligent power adjustment, EVLA will maintain its dominant position in minimally invasive vascular treatment, balancing therapeutic efficacy, cosmetic outcomes and patient experience.